Biotechnology company Advanced Enzyme Technologies announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from operations on consolidated basis increased to Rs 1,672 million in the Q4FY25 from Rs 1,578 million in the Q4FY24, a growth of 6% EBITDA margin stands at 27%, PBT margin stands at 26% and PAT margin stands at 16% during the quarter Consolidated EBITDA during Q4FY25 stands at Rs 456 million as compared to Rs 554 million during Q4FY24, declined by 18% Profit before tax stands at Rs 435 million during Q4FY25 as against Rs 396 million in Q4FY24, increase of 9% Profit after tax de-grew by 11% and stands at Rs 267 million during Q4FY25 as compared to Rs 299 million during the Q4FY24 Earnings Per Share during Q4FY25 stands at Rs 2.37 as compared to Rs 2.53 in Q4FY24 FY25 Financial Highlights: Revenue from operations on consolidated basis increased to Rs 6,369 million in the FY25 from Rs 6,239 million in the FY24, reported increase of 2% EBITDA margin stands at 31%, PBT margin stands at 29% and PAT margin stands at 21% during the FY25 Consolidated EBITDA during FY25 stands at Rs 1,944 million as compared to Rs 2,045 million during FY24, declined by 5% Profit before tax stands at Rs 1,874 million during FY25 as against Rs 1,879 million in FY24 Profit after tax stands at Rs 1,340 million during FY25 as compared to Rs 1,370 million during the FY24, declined by 2% Earnings Per Share during FY25 stands at Rs 11.72 as compared to Rs 11.92 in FY24 Result PDF